A detailed history of Ameritas Investment Partners, Inc. transactions in Incyte Corp stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 2,012 shares of INCY stock, worth $118,748. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,012
Previous 2,229 9.74%
Holding current value
$118,748
Previous $139,000 17.99%
% of portfolio
0.0%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$56.55 - $66.59 $12,271 - $14,450
-217 Reduced 9.74%
2,012 $114,000
Q4 2022

Feb 13, 2023

SELL
$67.18 - $84.11 $15,585 - $19,513
-232 Reduced 9.43%
2,229 $179,000
Q4 2021

Feb 11, 2022

SELL
$63.34 - $74.11 $312,772 - $365,955
-4,938 Reduced 66.74%
2,461 $181,000
Q2 2021

Aug 06, 2021

BUY
$79.87 - $87.53 $11,341 - $12,429
142 Added 1.96%
7,399 $622,000
Q4 2020

Feb 12, 2021

BUY
$80.74 - $97.7 $12,030 - $14,557
149 Added 2.1%
7,257 $631,000
Q3 2020

Nov 13, 2020

SELL
$85.07 - $109.69 $12,079 - $15,575
-142 Reduced 1.96%
7,108 $638,000
Q2 2020

Aug 05, 2020

BUY
$74.18 - $108.93 $2,967 - $4,357
40 Added 0.55%
7,250 $754,000
Q1 2020

May 13, 2020

SELL
$63.18 - $85.97 $12,446 - $16,936
-197 Reduced 2.66%
7,210 $528,000
Q4 2019

Feb 13, 2020

BUY
$73.04 - $95.72 $19,793 - $25,940
271 Added 3.8%
7,407 $647,000
Q2 2019

Aug 14, 2019

BUY
$73.52 - $88.7 $5,587 - $6,741
76 Added 1.08%
7,136 $606,000
Q1 2019

May 15, 2019

BUY
$63.56 - $88.17 $2,796 - $3,879
44 Added 0.63%
7,060 $607,000
Q4 2018

Feb 12, 2019

SELL
$58.5 - $69.94 $6,552 - $7,833
-112 Reduced 1.57%
7,016 $446,000
Q2 2018

Aug 13, 2018

SELL
$60.85 - $83.98 $25,800 - $35,607
-424 Reduced 5.61%
7,128 $478,000
Q4 2017

Feb 14, 2018

SELL
$93.56 - $116.6 $1,777 - $2,215
-19 Reduced 0.25%
7,552 $715,000
Q2 2017

Aug 15, 2017

BUY
N/A
7,571
7,571 $953,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $13.1B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Ameritas Investment Partners, Inc. Portfolio

Follow Ameritas Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.